Phase II trial of GVDexa (gemcitabine, vinorelbine and dexamethasone) regimen in relapsed/refractory Hodgkin's lymphoma.

被引：0
|
作者：
Mehra, Nikita
Ganesan, Prasanth
Jayachandran, P. K.
Joel, Anjana
Karunakaran, Parathan
Radhakrishnan, Venkatraman
Ganesan, Trivadi S.
Rathinam, Krishna
Gnana, Sagar Tenali
机构：
[1] Canc Inst WIA, Chennai, Tamil Nadu, India
[2] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
[3] Christian Med Coll, Vellore, Tamil Nadu, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19519
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Gemcitabine, Vinorelbine and Dexamethasone (GVDexa) As Second-Line Salvage Regimen in Relapsed and Refractory Hodgkin's Lymphoma
    Joel, Anjana
    Ganesan, Prasanth
    Sagar, Tenali Gnana
    Kannan, Krishnarathnam
    Ganesan, Trivadi
    Radhakrishnan, Venkatraman
    Rajendranath, Rejiv
    Sundersingh, Shirley
    Vikas, Vandana
    BLOOD, 2015, 126 (23)
  • [2] Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma
    Ganesan, Prasanth
    Mehra, Nikita
    Joel, Anjana
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Kalayarasi, Jayachandran Perumal
    Kannan, Krishnarathinam
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    LEUKEMIA RESEARCH, 2019, 84
  • [3] Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
    Santoro, Armando
    Magagnoli, Massimo
    Spina, Michele
    Pinotti, Graziella
    Siracusano, Licia
    Michieli, Mariagrazia
    Nozza, Andrea
    Sarina, Barbara
    Morenghi, Emanuela
    Castagna, Luca
    Tirelli, Umberto
    Balzarotti, Monica
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 35 - 41
  • [4] Phase I/II trial of infusional vinorelbine in relapsed or refractory lymphoma.
    Sarris, AH
    Psyrri, A
    Romaguera, J
    Hagemeister, F
    McLaughlin, P
    Bachier, C
    Mesina, O
    Adams, LM
    Cabanillas, F
    BLOOD, 1998, 92 (10) : 621A - 621A
  • [5] Non-Platinum Containing Regimen of Gemcitabine, Vinorelbine and Dexamethasone as Salvage Therapy in Relapsed/Refractory Hodgkin's Lymphoma
    Ganesan, Prasanth
    Mehra, Nikita
    Joel, Anjana
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Jayachandran, P. K.
    Shankar, Krupa
    Ganesan, Trivadi S.
    Sagar, Tenali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S230 - S230
  • [6] Gemcitabine, dexamethasone, and cisplatin (GDP) as an effective therapy as salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma.
    Gokmen, Ayla
    Soydan, Ender
    Gokgoz, Zafer
    Kurdal, Mevlude
    Tek, Ibrahim
    Ilhan, Osman
    Arslan, Onder
    Ozcan, Muhit
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [9] Gemcitabine as a single agent in the treatment of relapsed or refractory Hodgkin's and Non Hodgkin's lymphoma.
    Jajeh, A
    Hadad, L
    Godo, C
    Nukala, S
    BLOOD, 2001, 98 (11) : 242B - 243B
  • [10] Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial
    Liu, Yanfei
    Ping, Lingyan
    Song, Yuqin
    Tang, Yongjing
    Zheng, Wen
    Liu, Weiping
    Ying, Zhitao
    Zhang, Chen
    Wu, Meng
    Feng, Feier
    Lin, Ningjing
    Tu, Meifeng
    Zhu, Jun
    Xie, Yan
    BMC MEDICINE, 2024, 22 (01)
12345